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HRS/J Hairless mice have been investigated as an experimental model in cutaneous leishmaniasis
induced by Leishmania (Leishmania) amazonensis. The animals were inoculated with 106 promastigotes
into the right hind footpad and the course of infection was followed up for 30, 60 and 90 days. BALB/c
mice were infected and used as control. Hairless mice were susceptible to L. (L.) amazonensis infection
and a progressive increase in number of parasites and footpad thickness was detected over time. Signals
of dissemination and visceralization were conﬁrmed by the presence of parasite in the draining lymph
node of lesion and spleen, at different times post infection. IL-10 gene expression evaluated by RT-PCR
was signiﬁcantly higher in Hairless mice at 60 days post infection, corroborating the pattern of sus-
ceptibility. These results point this inbred strain as a promising susceptible model for the study of
experimental infection induced by L. (L.) amazonensis. This model would allow the use of other infectiona Humana, Centro de Cie^ncias
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V.C.P. Araujo et al. / Experimental Parasitology 157 (2015) 138e144 139sites that minimize secondary interference and best monitoring the skin lesion, as in the case of in vivo
assays of potential drugs for LT.
© 2015 Elsevier Inc. All rights reserved.1. Introduction
Leishmaniases are a group of non-contagious infectious dis-
ease caused by protozoal parasites of the genus Leishmania
(Kinetoplastida: Trypanosomatidae) transmitted to humans
through the bite of phlebotomine sand ﬂies (Monzote, 2009;
WHO, 2010). Cutaneous leishmaniasis (CL) has a wide spectrum
of manifestations, evolving into chronic skin lesions or possible
spontaneous healing (Brasil, 2010). These clinical manifestations
of CT are associated with speciﬁc characteristics of each host, with
Leishmania species and also with the immune response of the
infected individual (Reithinger et al., 2007). Leishmania (Leish-
mania) amazonensis is one of the etiological agents of American
Cutaneous Leishmaniasis (ACL), causing skin lesions associated
with Localized Cutaneous Leishmaniasis (LCL) or, in anergic in-
dividuals, multiple non-ulcerative nodules (Diffuse Cutaneous
Leishmaniasis e DCL) (Silveira et al., 2004; Azeredo-Coutinho
et al., 2007).
Murine cutaneous leishmaniasis has emerged as a model to
study the development and control of cell-mediated immune
response, and susceptibility to Leishmania is genetically determined
among the various strains of mice (Pearson andWilson,1988; Sacks
and Noben-Trauth, 2002). Since then, these models are important
for both the study and understanding of the pathogenesis and the
development of vaccines (Brodskyn et al., 2003; Oliveira and
Barral-Neto, 2005; Pereira and Alves, 2008).
CL has been generally studied with experimental models us-
ing subcutaneous or intradermal routes, in the footpad, base of
the tail or in the ear (Loría-Cervera and Andrade-Narvaez, 2014;
Moura et al., 2010; Wege et al., 2012). These models have been
used in in vivo tests of new drugs for the treatment of CL, by oral
or intralesional administration, as well as tattooing (Minodier
and Parola, 2007; Shio et al., 2014; Tiuman et al., 2012). All
these works, however, have been performed using hair-bearing
mice.
Mutant Hairless mice present progressive loss of hairs. They
have been widely used to study the poor cycle of hairs, and also
to test products that reduce skin aging, the damage caused by
UVB rays and by treatment with acids, as well as the study of
healing of inﬂammation-associated wounds (Benavides et al.,
2009; Massironi et al., 2005; Perez et al., 2012). Hairless mice
are a promising model for the study of CL once the disadvan-
tages of the presence of hair would be minimized, such as
secondary infections and discontinuity caused by the hair
removal. They could provide different sites of infection, opti-
mizing the monitoring of the development of cutaneous lesion
and the evaluation of treatment schedules, besides avoiding
potential hypersensitivity reactions arising from the epilation.
The aim of this work was the investigation of HRS/J Hairless
mice as an experimental model in the CL induced by L. (L.) ama-
zonensis. In the present study, these animals showed a pattern of
susceptibility that would be a tool to elucidate important aspects
of hosteparasite relationship, once this species is associated to an
important clinical manifestation in anergic individuals in South
America.2. Materials and methods
2.1. Animals
Fifty ﬁve male inbred HRS/J mice, known as Hairless, were used
as experimental model of infection. The animals were obtained
from the animal facility of the campus of Ribeir~ao Preto, University
of S~ao Paulo (USP, Brazil), and kept in mating regime at the central
animal facility of the Center for Biological and Health Sciences
(CCBS) of the Federal University of Mato Grosso do Sul (UFMS,
Brazil). Mice aged 4e6 weeks were maintained in individually
ventilated cages equipped with mini-isolators, fed a balanced feed
(Nuvilab CR-1, Nuvital®) with free access to water. This study
received approval from the local Animal Experimentation Ethics
Committee (CEUA/UFMS) under protocol number 412/2012.2.2. Parasites
A standard strain of L. (L.) amazonensis (IFLA/BR/1967/PH8) was
used for the establishment of infection. Amastigotes were routinely
isolated from Golden hamsters (Mesocricetus auratus) and main-
tained as promastigotes in Schneider's Insect Medium (Sigma)
supplemented with 20% fetal bovine serum (FBS, Cultilab) and
140 mg/mL gentamicin (Sigma) at 25 C. On the 7th day of cultiva-
tion, promastigotes from up to 4e10 serial passages after isolation
were used in the experiments. Silva Jr. et al. (2015) showed that the
percentage of metacyclic forms of this strain ranged from 38 to 69%
on the 6th day of culture as detected by morphometry, ﬂow
cytometry, lectin/antibody selection and complement resistance,
using 3rde6th passage parasites.2.3. Infection and monitoring of cutaneous lesion
Mice of both strains were infected subcutaneously (sc) in the
right hind footpad with 1  106 L. (L.) amazonensis promastigotes
(1 106/0.1 mL/PBS), and divided into groups of ﬁve. The kinetics of
the cutaneous lesion was evaluated 30, 60 and 90 days post
infection (p.i.). Footpad thickness was measured using a caliper
with an accuracy of 0.01 mm (Worker®) and was expressed as the
difference between the infected and the mean of ﬁve non-infected
footpads.2.4. Evaluation of parasite load
Parasite load was evaluated at the inoculation site, popliteal
draining lymph node, and spleen at different times of infection in
ﬁve animals. The organs were removed, weighed and homogenized
in 1 mL of Schneider's Insect Medium (Sigma) supplemented with
20% FCS (Sigma) and 140 mg/mL gentamicin (Sigma). The limiting
dilution assay was performed in duplicate, as previously described
(Titus et al., 1985). The parasite load was calculated using the
geometric mean reciprocal of positive titers obtained for the ho-
mogenate of each organ divided by the respective weight and the
number of parasites per nanogram of tissue was then calculated.
Fig. 1. Kinetics of cutaneous lesions induced by L. amazonensis. The animals were
subcutaneously infected into the right hind footpad with 106 promastigotes. Footpad
thickness was measured with a caliper and expressed as the difference between the
infected and the mean of ﬁve uninfected footpads. Data represent the mean ± SD of
ﬁve animals per group. *p < 0.001 for Hairless 30  60 days, 30  90 days and 60  90
days (ANOVA followed by Tukey post-test). #p < 0.001 for BALB/c 30  60 days,
30  90 days and #p < 0.05 for BALB/c 60  90 days (ANOVA followed by Tukey's post-
test). **p ¼ 0.0311 for Hairless  BALB/c 30 days post infection, **p ¼ 0.0041
Hairless BALB/c 60 days post infection and **p ¼ 0.0116 for Hairless BALB/c 90 days
post infection (Student's t-test).
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Five animals from each experimental group were used for the
histopathological analysis of the infected footpad, draining lymph
node and spleen. Five uninfected animals of each strain were used
as controls. The organs were removed and ﬁxed in 10% buffered
formalin for subsequent embedment in parafﬁn. Sections (5 mm)
were cut on a microtome (Zeiss Hyrax M25) and stained with
Hematoxylin-Eosin (HE). The analysis involved the determination
of the nature of the inﬂammatory inﬁltrate and the presence of
parasite forms. Photomicrographs were taken on an image-
capturing microscope (Leica DM5500B).
2.6. RNA isolation and real-time PCR
60 days after infection, the animals of both strains were
euthanized; infected footpads were removed and stored in buffer
solution (350 mL TRIZOL®, Invitrogen, Carlsbad, CA). They were
mechanically lysed using MagNALyzer® (Roche Molecular Sys-
tems). Nanodrop ND-1000 (Thermocientiﬁc®) was used to quantify
the total amount of extracted RNA, and 1 mg was used for the c-DNA
synthesis. The c-DNAwas used for detecting cytokines by Real-Time
(RT) PCR. The levels of gene expression (INF-g, TNF-a and IL-10)
were calculated using GAPDH as a housekeeping gene. The reac-
tion began with the activation of the enzyme present in Mastermix
(SYBR Green®, Invitrogen) for 10 min at 50 C and 1 min at 95 C.
The cycling occurred with annealing and extension at the same
time for 15 s at 95 C and 1 min at 60 C, repeated 40 to 50 times.
The analysis was calculated in triplicate using ABI Prism 7500
(Applied Biosystems, Inc., Fullerton, CA, USA). Threshold cycles (Ct)
were normalized according to GAPDH gene ampliﬁcation deter-
mined by DCt ¼ Ct (target gene)  Ct (GAPDH gene). The relative
expression was calculated using 2DDCt, where
DDCt ¼ DCt(target)  DCt, compared to uninfected animals (con-
trols). Primers employed herein are described elsewhere, where
the PCR assays were validated (Moura et al., 2010; Carneiro et al.,
2012; Santos et al., 2012).
2.7. Statistical analysis
Footpad thickness, parasite load and gene expression of cyto-
kines were expressed as the mean ± standard deviation (SD) of ﬁve
animals per group, respectively, and the data were analyzed using
ANOVA followed by Tukey post test when the observation occurred
intra-lineage (Hairless  Hairless); and Student's t-test when inter-
lineage (Hairless BALB/c). Differences were considered signiﬁcant
at p < 0.05 (represented by an asterisk).
3. Results and discussion
This study presents the ﬁrst results of the use of murine strain
HRS/J (Hairless) as a model in experimental CL induced by L. (L.)
amazonensis. To date, the only study using Hairless mice e albino
mice of unmentioned genetic background e in experimental CL
was carried out by Packchanian (1979), whose preliminary results
showed progressive lesions in animals infected with Leishmania
tropica at the base of tail. The successful infection of Hairless mice is
the ﬁrst step of a study that aims at the development of other sites
of infection apart from the footpad, where the cutaneous lesion
could be best induced and accompanied withminimized secondary
infections. The use of BALB/c mice as controls has provided a ﬁrst
parameter of susceptibility, allowing the comparison of the same
infection site in both species.
The inoculation of promastigotes caused a progressive increase
in footpad thickness in both strains studied. When consideringHairless lineage, the increase was signiﬁcant (p < 0.001) between
the points of infection (30, 60 and 90 days). So was observed with
BALB/c mice, with the same level of signiﬁcance for 30 and 60 days
and 30 and 90 days. Comparing both lineages, the footpads of BALB/
c mice were signiﬁcantly greater on Day 30 (p¼ 0.0311) and Day 60
(p ¼ 0.0041). However, on Day 90, Hairless mice footpads were
thicker (p ¼ 0.0116) than those of BALB/c (Fig. 1).
The kinetics of skin lesion at the infection sitewas similar to that
found by Cupolilo et al. (2003), who infected three susceptible
strains with L. (L.) amazonensis. All strains presented progressive
increase in lesion until 90 days p.i. In our study, Hairless mice
demonstrated greater range in footpad thickness, making the
distinction between the periods analyzedmore accurate. This range
would enable researchers to clinically deﬁne the best time to use
the experimental model for a certain objective, thenmaking the use
of Hairless advantageous compared to BALB/c. For example, Costa
Filho et al. (2008) used the analysis of the effects of different
treatments on cutaneous lesions as a clinical criterion.
The parasite load correlatedwith the kinetics of lesion at the site
of infection, where a progressive and signiﬁcant increase was
observed in Hairless mice (Fig. 2). Parasite load of BALB/c mice
increased from 30 to 60 days p.i., but signiﬁcantly decreased from
60 to 90 days p.i. (Fig. 2). In the draining popliteal lymph node,
parasites were detected in both strains, but no signiﬁcant difference
was seen as to the periods (Fig. 2). Nor was a signiﬁcant difference
seen between the strains in different periods. In the spleen, para-
sites were detected as early as 30 days p.i., although in a small
number in both strains. In Hairless mice, a signiﬁcant increase was
observed between 30 and 90 days, which was not seen in BALB/c
mice (Fig. 2). This relevant detection of parasites indicates viscer-
alization of infection in Hairless mice, a largely described condition
for L. (L.) amazonensis-infected BALB/c mice, as previously
mentioned.
Histopathological study corroborated the clinical characteris-
tics of footpad thickness, and demonstrated the high suscepti-
bility of both strains to L. (L.) amazonensis infection. The animals
showed parasitism from the ﬁrst point of infection, becoming
intensiﬁed over time. Thirty days after infection, Hairless mice
footpads had superﬁcial lesions, with parasites already being
observed. Regarding the inﬂammatory inﬁltrate a predominantly
macrophage response was seen, with some lymphocytes and
plasma cells. Insofar as the infection progressed (60 days), new
Fig. 2. Parasite load in footpads, draining lymph nodes and spleen of Hairless and
BALB/c mice. The animals were subcutaneously infected into the right hind footpad
with 106 L. amazonensis promastigotes. Parasite load was determined 30, 60 and 90
days after infection via a limiting dilution assay. Values represent the mean ± standard
deviation of ﬁve animals per group. ap ¼ 0.0005 for Hairless  BALB/c mice e 30 days
(Student's t-test). bp ¼ 0.0014 for Hairless  BALB/c mice e 60 days (Student's t-test).
cp ¼ 0.0304 for Hairless  BALB/c mice e 90 days (Student's t-test). dp < 0.001 for
BALB/c mice, 30  60 days; 60  90 days (ANOVA followed by Tukey post test).
ep < 0.005 for Hairless 30  90 days; 60  90 days (ANOVA followed by Tukey post
test). #p < 0.01 for Hairless, 30  90 days (ANOVA followed by Tukey post test).
*p < 0.05 for Hairless 60  90 days (ANOVA followed by Tukey post test).
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days, a disruption of epidermis occurred, giving rise to a typical
ulcer. The lesion presented intense diffuse necrosis, macroscopi-
cally showing aspect of crust. At this point, a large amount of
heavily infected macrophages could be visualized (Fig. 3C). In the
lymph nodes, no parasitic forms were observed 60 days p.i. Ninety
days after infection, however, a large amount of tissue had been
replaced by intense inﬁltration of parasitized macrophages
(Fig. 3E). Similar results were found in BALB/c mice. On Day 30 p.i.,
the footpads showed discrete lesion, with the presence of infected
cells and mild inﬂammatory inﬁltrate. After 60 days (Fig. 3B), thelesion had expanded and, 90 days p.i., the entire structure of the
footpad was already impaired, showing severe inﬂammatory
inﬁltrate composed mainly of densely parasitized macrophages
(Fig. 3D). Parasitism was discrete in the popliteal lymph node 30
days p.i., with scarce parasitized cells under the capsule, in the
cortical region. On Days 60 and 90, parasites were already seen
with greater intensity in the latter (Fig. 3F). No alterations were
observed in the spleens of infected animals during the experi-
ment. Similar results were described in BALB/c mice by Abreu-
Silva et al. (2004), Cupolilo et al. (2003) and Falú et al. (2009).
A signiﬁcantly higher expression (p¼ 0.00181) of gene IL-10was
observed in the infection site of Hairless mice (Fig. 4). Originally
described as an inhibitor of activation of T-helper cells and pro-
duction of Th1 cytokines (Fiorentino et al., 1989), IL-10 is expressed
by various cell types such as macrophages, dendritic cells, B cells
and several subsets of cells, such as Th2, regulatory T (Treg) and NK
cells (Moore et al., 2001). Thus, this cytokine is classically associated
with Th2 proﬁle, which, in leishmaniasis, is related to susceptibility
and inability to control the infection (Nylen and Sacks, 2007). The
higher expression on IL-10 in Hairless compared to BALB/c mice
may be associated to the progressive parasite load in the footpads
until 90 days p.i. BALB/c mice showed a decrease in parasite load
from 60 to 90 days p.i., but footpad thickness continued to increase,
though less than those of Hairless mice. Padigel et al. (2003)
showed that BALB/c IL-10/ mice infected with L. (L.) ama-
zonensis had lower parasite loads in the infection sites (footpad)
and draining lymph nodes than wild-type ones, evincing the in-
ﬂuence of this cytokine in the control of infection; nonetheless the
deﬁciency in endogenous IL-10 had little effect on lesion
development.
The progression of CL is associated with intracellular survival
of parasites and deactivation of macrophages (Moura et al., 2005;
Fiorentino et al., 1991). In Leishmania-susceptible mice the in-
crease of parasitized macrophages are observed with the pro-
gressive evolution of lesion. In resistant animals, on the other
hand, the increase in number of lymphocytes and the decrease in
number of infected macrophages are observed over time, and the
inﬂammatory inﬁltrate becomes scarce with the resolution of
lesion (Andrade et al., 1984; Souza et al., 2000). Homozygous
hairless mice (hrehr) are known to have about 30% more mac-
rophages (Suzu et al., 2000; The Jackson Laboratories, 2014),
which could contribute to the susceptibility pattern of these
animals, including the fact that these cells constitute a source of
IL-10. Theferore macrophages may play a role in disease exac-
erbation during the initial stages of L. (L.) amazonensis infection
(Pereira and Alves, 2008). Furthermore Hairless mice exhibit a
mild immunodeﬁciency, associated with abnormalities in T-cells
(Morrisey et al., 1980; Rezke-Kunz et al., 1979). Zarach et al.
(2004) showed that the Hr gene encodes a protein highly
expressed in skin and brain, which acts as a transcriptional co-
repressor for some nuclear receptors such as thyroid hormone,
retinoic acid, and vitamin D receptors. Mutations in the Hr gene
could unsettle the transcriptional products of genes related to
cell mediated immunity, as showed by Cunliffe et al. (2002).
Schaffer et al. (2010) evaluated some cellular and humoral
immunological aspects of the SKH1 mouse strain, but the animals
were considered as immune competent. Studies should be car-
ried out in order to investigate the role of these proteins on
immunological functions of HRS/J Hairless mice, mainly on the
gene expression associated to immune response in the skin,
where Leishmania infection initially takes place. Once the chosen
experimental model affects the immunoregulatory events during
the infection, Hairless mice may bring some information
regarding the immunological proﬁle triggered by L. (L.)
amazonensis.
Fig. 3. Histopathological analysis of the site of infection and popliteal lymph node in Hairless (A, C, E) and BALB/c (B, D, F) mice. The animals were subcutaneously infected with 106
L. amazonensis promastigotes into the right hind footpad. Footpad fragments were obtained 60 (A, B) and 90 (C, D) days post infection. A large number of vacuolated macrophages
containing numerous amastigotes was seen in both Hairless and BALB/c footpads (arrows). In popliteal lymph nodes a large number of parasites (arrows) is observed after 90 days in
Hairless mice (E). Some parasites are seen at the same point in the lymph nodes of BALB/c mice (F). The ﬁgure represents ﬁve animals analyzed in each group. HE staining.
Magniﬁcation: 1000 (A, B, C-window, D-window, E, F); 400 (C, D).
Fig. 4. Cytokine expression in the footpads of Hairless and BALB/c mice. The animals
were subcutaneously infected into the right hind footpad with 106 L. amazonensis pro-
mastigotes. Relative quantiﬁcation of IFN-g, TNF-a, and IL-10 at the infection site was
carried out 60 days after infection. Cytokine cycle threshold (Ct) values were normalized
toGAPDH expression (housekeeping) as determined byDCt¼ Ct(cytokine) Ct(GAPDH). Fold
change was determined by real-time PCR, using the 2DDCt method, where
DDCt ¼ DCt(experimental)  DCt(control). Data (mean ± SD of three animals per group)
represent the fold increase in gene expression of infected over uninfected mice.
*p ¼ 0.00181 for Hairless  BALB/c mice. Student's t-test.
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dominance of Th1 or Th2 responses cannot be established, due to
the different degrees of susceptibility among strains (Abreu-Silva
et al., 2004; Diaz et al., 2003; Torrentera et al., 2002; Pereira and
Alves, 2008). In inbred mice, several patterns of disease are
observed, except in Leishmania major infection. The inability to
stimulate a proper Th1 response is believed to be responsible for
the chronicity of lesions induced by the parasites of Leishmania
mexicana complex, including L. (L.) amazonensis (McMahon-Pratt
and Alexander, 2004). The accurate role of the Th2-type response
remains inconclusive, with seemingly contradictory information,
especially with respect to the production of some cytokines
(Alexander et al., 1999; Brombacher, 2000; Carrera et al., 1996;
Guler et al., 1996; Jones et al., 2000; Kropf et al., 1997).
The study of immune response in experimental leishmaniasis is
important to the understanding of the mechanisms involved in
resistance or susceptibility to different Leishmania species. It pro-
vides data to clarify the factors responsible for the different clinical
forms of the disease and the wide spectrum of possible immune
responses, which could contribute to the development of more
effective vaccines and treatments against the disease.
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The present study demonstrated the susceptibility of Hairless
mice to L. (L.) amazonensis infection, with progressive lesions and
chronic persistence of the parasite in the site of infection, besides
the susceptibility pattern of expressed cytokines. Signs of prolifer-
ation and visceralization were conﬁrmed by the presence of para-
sites in the spleen and the draining lymph nodes of lesion. Studies
are being carried out to establish the cutaneous lesion in other sites
of infection in these animals.
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